The B.Pharma Lateral Entry (LEET) program at Puran Murti Campus is a strategic academic pathway designed specifically for students who have already earned a diploma in pharmacy (D.Pharma). In the 2026 academic session, this program allows diploma holders to bypass the first year of the standard four-year degree and join the Bachelor of Pharmacy (B.Pharma) program directly in the second year (3rd semester). This "2+3" model (two years of diploma plus three years of degree) ensures that students' prior technical training is fully recognized, effectively saving them one full year of study and tuition fees.
To be eligible for this advanced placement, candidates must have successfully completed their D.Pharma from an institution approved by the Pharmacy Council of India (PCI). Most regulatory frameworks in 2026 require a minimum aggregate of 50% marks in the diploma for general category students, with a 5% relaxation typically provided for SC/ST candidates. This entry route is ideal for working professionals or recent diploma graduates who wish to upgrade their clinical knowledge and qualify for higher-tier roles in the pharmaceutical industry that require a full degree.
The transition into the second year is seamless because the D.Pharma curriculum covers much of the foundational anatomy and basic chemistry taught in the first year of B.Pharma. However, once in the degree track, lateral entry students dive deeper into advanced subjects such as medicinal chemistry, pharmacology I and physical pharmaceutics. These students often hold a practical advantage in the laboratory, as their two years of diploma study have already provided them with significant "hands-on" experience in compounding and dispensing medications, which they can now apply to more complex drug delivery systems.
Financially and professionally, the LEET program offers a high return on investment (ROI). By skipping the first year, students save approximately ₹1,25,000 to ₹1,50,000 in tuition fees, along with associated hostel and library costs. More importantly, it accelerates their entry into the professional job market as "degree-qualified pharmacists." In the 2026 healthcare sector, this allows them to apply for prestigious positions such as drug inspectors, quality control managers, or clinical research associates a year earlier than if they had started as freshmen, significantly boosting their lifetime earning potential.
Ultimately, the B.Pharma Lateral Entry program at Puran Murti Campus empowers students to reach the "Licensed Professional" status with greater efficiency. Graduates from this track are eligible for the same high-tier placements at firms like Sun Pharma, Cipla and Dr. Reddy's as regular B.Pharma students. By bridging the gap between a diploma and a degree, the campus ensures that skilled pharmacy technicians can evolve into visionary pharmaceutical scientists who are capable of leading drug discovery and healthcare management in the late 2020s.